Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 1257
Conférences

le (13m7s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Efthymios DELIARGYRIS)

... final position yet. Implementation of adaptive designs requires early and in-depth interaction between the agencies and study sponsors.➢ With the newer anti-thrombotic agents progressively potentially replacing warfarin, we are moving from a target INR...
Voir la vidéo
Conférences

le (52m37s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Faiez ZANNAD)

... final position yet. Implementation of adaptive designs requires early and in-depth interaction between the agencies and study sponsors.➢ With the newer anti-thrombotic agents progressively potentially replacing warfarin, we are moving from a target INR...
Voir la vidéo
Conférences

le (9m33s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 1 : New indications: Is heart failure a viable new potential indication for anti-thrombosis therapy (Krishna PRASAD)

... final position yet. Implementation of adaptive designs requires early and in-depth interaction between the agencies and study sponsors.➢ With the newer anti-thrombotic agents progressively potentially replacing warfarin, we are moving from a target INR...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte